DK0571670T3 - Farmaceutiske præparater til anvendelse som mastcellestabilisator - Google Patents

Farmaceutiske præparater til anvendelse som mastcellestabilisator

Info

Publication number
DK0571670T3
DK0571670T3 DK92304711.2T DK92304711T DK0571670T3 DK 0571670 T3 DK0571670 T3 DK 0571670T3 DK 92304711 T DK92304711 T DK 92304711T DK 0571670 T3 DK0571670 T3 DK 0571670T3
Authority
DK
Denmark
Prior art keywords
mast cell
pharmaceuticals
cell stabilizers
ingredient
stabilization
Prior art date
Application number
DK92304711.2T
Other languages
English (en)
Inventor
Ann Louise Bazin
Patricia Elaine Koochaki
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK0571670T3 publication Critical patent/DK0571670T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92304711.2T 1992-05-26 1992-05-26 Farmaceutiske præparater til anvendelse som mastcellestabilisator DK0571670T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92304711A EP0571670B1 (en) 1992-05-26 1992-05-26 Pharmaceutical compositions for use as mast cell stabilizer

Publications (1)

Publication Number Publication Date
DK0571670T3 true DK0571670T3 (da) 1997-08-18

Family

ID=8211373

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92304711.2T DK0571670T3 (da) 1992-05-26 1992-05-26 Farmaceutiske præparater til anvendelse som mastcellestabilisator

Country Status (6)

Country Link
EP (2) EP0571670B1 (da)
AT (1) ATE148627T1 (da)
DE (1) DE69217357T2 (da)
DK (1) DK0571670T3 (da)
ES (1) ES2097282T3 (da)
GR (1) GR3022503T3 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849263A (en) * 1993-03-30 1998-12-15 Charlotte-Mecklenburg Hospital Authority Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
US6147081A (en) * 1996-09-26 2000-11-14 Rohto Pharmaceutical Co., Ltd. Ophthalmic solution
WO2000016771A1 (fr) * 1998-09-24 2000-03-30 Fujisawa Pharmaceutical Co., Ltd. Preparations liquides a usage externe contenant du cromoglycate de sodium et traitement ou prevention des symptomes allergiques oculaires
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
CN104634628B (zh) * 2014-12-16 2017-03-29 广东腾飞基因科技有限公司 一种血液稳定剂及其应用
WO2020234439A1 (en) * 2019-05-22 2020-11-26 Ac Bioscience Sa Composition and use thereof for the treatment of cutaneous mastocytosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715975A (da) * 1967-11-24 1969-05-28

Also Published As

Publication number Publication date
ES2097282T3 (es) 1997-04-01
EP0571670A1 (en) 1993-12-01
DE69217357T2 (de) 1997-07-10
DE69217357D1 (de) 1997-03-20
EP0571670B1 (en) 1997-02-05
GR3022503T3 (en) 1997-05-31
ATE148627T1 (de) 1997-02-15
EP0670161A1 (en) 1995-09-06

Similar Documents

Publication Publication Date Title
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
AU6542986A (en) Pyridyl-methylthio substituted benzimidazoles
EP1043324A4 (en) PURINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT
UA26303A1 (uk) Фармацевтичhа композиція, яка має імуhосупресорhу та аhтимікробhу активhість
DK0638317T3 (da) Farmaceutisk præparat, der indeholder glucosidase- og/eller amylasehæmmere og lipasehæmmer
KR950700282A (ko) S-트리아진 유도체 및 이를 활성성분으로서 함유하는 에스트로겐-의존성 질환 치료제(s-Triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient)
DK0600544T3 (da) Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater
FI870457A0 (fi) Farmaceutiska preparatformer foer stabilisering av interferon- .
BR8604535A (pt) Composicao inseticida compreendendo mais que um ingrediente ativo
DK0603649T3 (da) Substituerede 4-phenyl-pyridoner og 4-phenyl-2-alkoxypyridiner som HMG-CoA-reduktase-inhibitorer
DK0571670T3 (da) Farmaceutiske præparater til anvendelse som mastcellestabilisator
ATE128363T1 (de) Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
NO923721L (no) 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
NO882509D0 (no) Nye pyrazolforbindelser og herbicide preparater inneholdende dem som aktive bestanddeler.
IT8021550A0 (it) Derivati adenosinici ad attivita'antinfiammatoria ed analgesica e composizioni terapeutiche che licontengono come principio attivo.
DE69318710T2 (de) Antitussivum
NO301826B1 (no) Heterotricyklisk substituerte fenylcykloheksankarboksylsyrederivater, legemidler inneholdende dem og deres anvendelse for fremstilling av legemidler
DK0533516T3 (da) Hidtil ukendte 1-(alkoxybenzyl)piperazinamidforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK1200088T3 (da) Sammensætning indeholdende paracetamol og drotaverin
DK0578535T3 (da) Hidtil ukendt peptid-derivater, der er aktive i celleadhæsionsprocesser, fremgangsmåde til deres fremstilling samt farmaceutiske sammensætninger indeholdende derivarerne
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
ES2063020T3 (es) Formulacion medicamentosa de absorcion transdermica.
ZA891784B (en) Peptides with pharmaceutical activity
EP0264017A3 (en) Pharmaceutical compositions having healing activity